WO2024028790 - COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE
National phase entry:
Publication Number
WO/2024/028790
Publication Date
08.02.2024
International Application No.
PCT/IB2023/057837
International Filing Date
02.08.2023
Title **
[English]
COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE
[French]
COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE LA DRÉPANOCYTOSE
Applicants **
BEREN THERAPEUTICS P.B.C.
Inventors
PYRAH, Ian
NIESOR, Eric
Priority Data
63/394,938
03.08.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2896 | |
| EPO | Filing, Examination, Granting | 23860 | |
| Japan | Filing, Examination, Granting | 3145 | |
| South Korea | Filing, Examination, Granting | 3857 | |
| USA | Filing, Examination, Granting | 10340 |
Total:
44,098
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure provides methods and compositions for treating or preventing a sickle cell disease (SCD). The SCD may include sickle cell anemia (SCA). The method may include administering a composition such as a cyclodextrin to a subject in need of SCD treatment. Some embodiments include contacting a RBC with a cyclodextrin.[French]
La présente invention concerne des méthodes et des compositions pour traiter ou prévenir une drépanocytose (SCD). La SCD peut comprendre l'anémie drépanocytaire (SCA). La méthode peut consister à administrer une composition telle qu'une cyclodextrine à un sujet ayant besoin d'un traitement contre la SCD. Certains modes de réalisation comprennent la mise en contact d'un globule rouge (GR) avec une cyclodextrine.